Medical News

RSS

OpenTrust to secure wireless network access for 4,000 iPhone, iPad users of global pharma company

OpenTrust, the Next-Gen IT security software publisher, today announced that it will secure wireless network access for users of 4,000 iPhones and iPads for a leading global organization.

26 Oct 2010

Researchers find new antibiotic strategies for hibernating bugs

New strategies to apply antibiotics more effectively to hibernating bugs have been developed by researchers at the University of Hertfordshire.

26 Oct 2010

Independent drugstores expand and generate strong profits despite worst economy

Amidst the worst economy of the past seventy years, independent drugstores are expanding and generating strong profits, according to a new economic report by the National Community Pharmacists Association (NCPA). The report shows that there are almost 400 more independent drugstores than last year and that profits (3.2%) are three times greater than the rate of U.S. inflation (1.1%).

26 Oct 2010

DGAC Report highlights effective approaches to facilitate better eating habits among Americans

In an insightful Commentary in the November issue of the Journal of the American Dietetic Association, Linda Van Horn, PhD, RD, Editor-in-Chief of the Journal, Chair of the Dietary Guidelines Advisory Committee, and Professor and Associate Dean, Northwestern University, Feinberg School of Medicine, highlights the key features and noteworthy findings of the 2010 US Dietary Guidelines Advisory Committee (DGAC) Report.

26 Oct 2010

Rush and UHC awarded $500,000 grant to boost medical travel to U.S. academic medical centers

Rush University, in partnership with the University HealthSystem Consortium (UHC), has been awarded a three-year, $500,000 Market Development Cooperative Grant from the U.S. Department of Commerce to help boost medical travel to U.S. academic medical centers.

26 Oct 2010

Techulon signs exclusive license with Virginia Tech to market new theranostic transfection reagent

Techulon™ Inc., an early stage life sciences company based in the Virginia Tech Corporate Research Center, has signed an exclusive license with Virginia Tech Intellectual Properties Inc. to market a new theranostic transfection reagent. This new traceable reagent complements Techulon's currently marketed Glyocofect™ transfection platform and expands the company's offering in an $800 million market that is steadily growing at 15% annually.

26 Oct 2010

Novation, MedLearn enter agreement to provide unsurpassed coding, reimbursement expertise to health care organizations

Novation and MedLearn have entered into a three-year service provider agreement to bring coding, compliance and reimbursement expertise to health care organizations across the country, the two companies announced today.

26 Oct 2010

Admissions for medication, drug-related conditions increase by 117% among Americans aged 45 and older

The number of hospital admissions among Americans ages 45 and older for medication and drug-related conditions doubled between 1997 and 2008, according to a new report released today by HHS' Agency for Healthcare Research and Quality. Medication and drug-related conditions include effects of both prescription and over-the-counter medications as well as illicit drugs.

26 Oct 2010

Cord Blood America updates progress on stem cell collection business in China

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced its Chairman, CEO and co-founder, Matthew Schissler, has updated progress on the Company's stem cell collection business in China in an interview with analyst Francis Gaskins.

26 Oct 2010

Omeros to develop new drugs for major diseases

The Life Sciences Discovery Fund (LSDF) today announced a $5 million grant to Seattle-based Omeros Corporation (NASDAQ: OMER) to discover, develop, and commercialize new drugs to treat a variety of major diseases. With successful generation of proceeds through partnering and the sales of drugs in the marketplace, an additional outcome of the grant would be establishment of a new non-profit initiative to advance the life sciences sector and improve health and economic growth in Washington state.

26 Oct 2010

RLJ launches insurance services

Robert L. Johnson, founder and chairman of The RLJ Companies (RLJ), today announced the launch of RLJ Insurance Services, created in conjunction with AV International, LLC (AVI), a minority business insurance firm providing services for state government, municipal and corporate clients.

26 Oct 2010

Place of birth, low SES and exposure to pests associated with asthma in U.S.-born children

Researchers from Tufts University pooled data from five previous epidemiological studies to investigate the prevalence of asthma in children in the Boston neighborhoods of Chinatown and Dorchester. Among children born in the United States, low socioeconomic status (SES) and exposure to pests (mice and cockroaches) were both associated with having asthma. Neither association was present in children born outside of the United States. The study was published online in advance of print in the Journal of Immigrant and Minority Health.

26 Oct 2010

Researchers identify signaling pathway that promotes metastasis of pediatric bone cancer

Researchers have identified an important signaling pathway that, when blocked, significantly decreases the spread of pediatric bone cancer. Their research showed that the Notch pathway and Hes1 gene play a key role in promoting the metastasis of osteosarcoma, the most common form of bone cancer in children.

26 Oct 2010

Pharmacopeias of US and Kazakhstan sign accord

With the mutual goal of improving the quality of pharmaceuticals worldwide, the United States Pharmacopeial Convention (USP) and the Republican State Enterprise (RSE) National Centre for Expertise of Drugs, Medical Products and Equipment ("the Centre") of the Ministry of Health of the Republic of Kazakhstan have entered into an agreement to share standards for the quality, purity, strength and identity of medicines.

26 Oct 2010

School leaving grades can predict suicide risk in young people

School leaving grades can be an indicator of an increased risk of suicide at a young age. A new study from the medical university Karolinska Institutet and the Swedish National Board of Health and Welfare, shows that young people leaving the Swedish elementary school (year nine at age 16) with the lowest average grades, run approximately three times the risk of committing suicide compared with those who graduate with top or very high grades.

26 Oct 2010

Athletic performance can improve after heat acclimation

Turning up the heat might be the best thing for athletes competing in cool weather, according to a new study by human physiology researchers at the University of Oregon.

26 Oct 2010

New Risk Stratification Index allows important clinical outcomes

Research published in the November issue of Anesthesiology describes development of a new Risk Stratification Index (RSI) that allows important clinical outcomes such as length-of-stay and mortality for surgical patients to be accurately compared among hospitals using only publically available billing data. The new risk stratification system is more accurate than existing outcomes measurements such as the Charlson Comorbidity Index (CCI) and the investigators have made it freely available.

26 Oct 2010

Contraband tobacco accounts for 43% of cigarettes consumed by Ontario students

A new study from The Centre for Addiction and Mental Health (CAMH) found that contraband tobacco accounts for 43% of all cigarettes consumed by Ontario high school daily smokers in grades 9 to 12.

26 Oct 2010

Innovative program for new graduate doctors to ensure safety prescription

A new software based program has recently been created for new graduate doctors to ensure they prescribe safely from day one on the wards.

26 Oct 2010

Pfizer's Sutent stands as first-line setting for treating renal cell carcinoma: Survey

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of renal cell carcinoma (RCC), the majority of surveyed European oncologists who favor Pfizer's Sutent indicate that they would switch to an emerging therapy only if it extended progression-free survival (PFS) by at least an additional two to three months, assuming the agent's safety and tolerability profile was comparable to that of Sutent.

26 Oct 2010

Medical News

OpenTrust to secure wireless network access for 4,000 iPhone, iPad users of global pharma company

Researchers find new antibiotic strategies for hibernating bugs

Independent drugstores expand and generate strong profits despite worst economy

DGAC Report highlights effective approaches to facilitate better eating habits among Americans

Rush and UHC awarded $500,000 grant to boost medical travel to U.S. academic medical centers

Techulon signs exclusive license with Virginia Tech to market new theranostic transfection reagent

Novation, MedLearn enter agreement to provide unsurpassed coding, reimbursement expertise to health care organizations

Admissions for medication, drug-related conditions increase by 117% among Americans aged 45 and older

Cord Blood America updates progress on stem cell collection business in China

Omeros to develop new drugs for major diseases

RLJ launches insurance services

Place of birth, low SES and exposure to pests associated with asthma in U.S.-born children

Researchers identify signaling pathway that promotes metastasis of pediatric bone cancer

Pharmacopeias of US and Kazakhstan sign accord

School leaving grades can predict suicide risk in young people

Athletic performance can improve after heat acclimation

New Risk Stratification Index allows important clinical outcomes

Contraband tobacco accounts for 43% of cigarettes consumed by Ontario students

Innovative program for new graduate doctors to ensure safety prescription

Pfizer's Sutent stands as first-line setting for treating renal cell carcinoma: Survey

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News